Managers
Grosvenor Capital Management and its affiliates have acquired Customized Fund Investment Group (CFIG) from Credit Suisse Group AG.
The combined business, with more than USD44bn in assets under management and over 375 professionals, will be one of the largest of its kind in the world.
"We are very pleased to complete our acquisition of CFIG. We are confident that the transaction fundamentally strengthens our platform and makes us a more valuable partner for our clients," says Michael Sacks, chief executive officer of Grosvenor. "Together, we will offer clients the ability to access the entire alternative investments landscape. And importantly,
Eurasia Capital and Mandalay Capital have completed an equity capital raising for Silk Road Ventures for gross proceeds of CAD5m.
Eurasia Capital and Mandalay Capital have acted as financial advisors and joint placement agents with the regards to this transaction. Both firms are retained to advise Silk Road Ventures on planned larger equity placement to be completed in February 2014.
Silk Road Ventures intends to use the proceeds of this private placement to invest in high growth frontier markets in Mongolia, Myanmar and Mozambique.
“We are pleased to assist Silk Road Ventures in this equity financing transaction,”
High Road Capital Partners’ portfolio company Accurate Components & Fasteners has completed the acquisition of All Tool Sales.
Based in Franksville, Wisconsin, All Tool Sales operates through two divisions: All Fasteners, a distributor of industrial fasteners used by original-equipment manufacturers; and All Tool Sales, a distributor of cutting tools and industrial supplies.
“All Tool Sales has a strong reputation for high-quality products and consultative services through its vendor-managed inventory programmes,” says Benjamin A Schnakenberg, High Road partner. “This acquisition expands our footprint and solidifies Accurate’s position as a leading provider of industrial fasteners and other industrial supplies to manufacturers
Ares Capital has acquired a diversified middle-market corporate loan portfolio managed by a global banking institution for approximately USD319m.
The portfolio is primarily comprised of first lien senior loans, and to a lesser extent, second lien loans and small equity co-investments.
The portfolio is comprised of 32 investments in 23 portfolio companies in industries that are generally similar to those in Ares Capital’s portfolio.
“As the banking industry faces increasing regulatory restrictions, we are seeing more opportunities such as this to purchase high-quality, middle-market loan portfolios from financial institutions where we see potential to create value,” says Michael
Oakley Capital Corporate Finance has advised on the sale of cloud services provider e-know.net to Nasstar to create a significant new quoted cloud hosting and applications business.
Nasstar has announced the proposed acquisition of Denara, the holding company of e-know.net, for an equity consideration of GBP13m. Oakley is advising Denara on the transaction.
e-know.net provides a comprehensive cloud services package, offering hosted desktop and hosted exchange services, with the ability to host a wide variety of software applications on behalf of clients, as well as providing hosted telephony and managed data network services. e-know.net has high recurring revenues and
ICL, a global minerals based products producer, has entered into a definitive agreement to acquire Vale Fertilizantes’s share in Fosbrasil, a joint venture producing purified phosphoric acid and raw materials for fertilisers located in Brazil.
The proposed transaction is subject to the approval of Brazilian competition authorities (CADE) and other customary approvals.
The purchase of Vale’s shares will increase ICL’s ownership share to a majority position in a major producer of phosphoric acid in South America.
The transaction supports and is in concert with ICL’s recent announcement on its new strategy “The Next Step Forward,” as the acquisition
HgCapital, the European sector-focused private equity investor, has acquired 91.85 per cent of Personal & Informatik (P&I), a payroll and transaction HR software provider, from The Carlyle Group.
Headquartered in Wiesbaden, Germany, P&I provides payroll and HR-related software to mid-market companies and the public sector in Germany and the surrounding region.
The company serves almost 4,000 direct and 15,000 indirect customers and generated revenue of EUR82m in FY 2013. The business offers software for the management of payroll, workforce, time management and human capital management. It typically services SMEs with 200 to 5,000 employees across industries as well as
The management board of Kabel Deutschland has signed a domination and profit and loss transfer agreement pursuant to section 291 of the German Stock Corporation Act between Kabel Deutschland as the controlled entity and Vodafone Vierte Verwaltungs as the controlling entity.
Vodafone Vierte Verwaltungs currently owns 76.57 per cent of the shares of Kabel Deutschland.
The domination and profit and loss transfer agreement still requires the approval by the extraordinary general meeting of Kabel Deutschland which is scheduled to take place in Munich on 13 February 2014.
In the agreement, Vodafone Vierte Verwaltungs offers to acquire the shares
CapVest, a European mid-market private equity firm, has acquired Scandza, a Nordic consumer food and beverage business.
Jan Bodd and Stig Sunde, who established Scandza in 2007 and will continue to lead the business, have significantly increased their shareholding as part of the deal.
Scandza, which recorded a turnover of EUR236m (NOK1.8bn) in 2012, has created a fast moving consumer goods platform by taking advantage of consolidation opportunities in what continues to be a fragmented Nordic food and beverage market.
Scandza holds a portfolio of market leading brands in chilled foods, snacking and baked goods. Its portfolio includes
Private equity firm Arsenal Capital Partners has acquired Certara, a provider of model-based drug development and data analytics software and consulting services to the biopharmaceutical research and development market.
Certara provides highly specialised and integrated solutions which consist of computer-based models supported by scientific consulting services and which span the discovery, pre-clinical and clinical stages of drug development.
Certara's solutions provide clients with significant reductions in the time and expense of bringing new drugs to market by enabling data-driven decisions which lead to more precisely designed studies with less risk of failure and improved subject safety– a benefit in
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
